Hepatitis D Virus Antigen ELISA Kit (DEIA073)

Regulatory status: For research use only, not for use in diagnostic procedures.

Write a review

Datasheet COA SDS
Size
96T
Sample
serum, plasma
Species Reactivity
Human
Intended Use
This kit is an enzyme-linked immunosorbent assay (ELISA) for qualitative determination of antigens to hepatitis D virus (HDV- Ag) in human serum or plasma (EDTA, heparin and Sodium Citrate). It is intended for use in clinical laboratories for diagnosis of patients related to infection with hepatitis D virus, and is good for the survey of epidemics.
Contents of Kit
Microplate: 96 well polystyrene microplates (12 strips of 8 wells) coated with purified antibodies reactive to HDV;
Negative Control: 1 ml, 1 vial;
Positive Control: 1 ml, 1 vial;
HRP-Conjugate Antigen: 6ml, 1 vial;
Extraction Solution: 6 ml, 1 vial;
TMB Solution A: 6 ml, 1 vial;
TMB Solution B: 6 ml, 1 vial;
TMB Stop Solution: 6 ml, 1 vial;
Wash Buffer (20×): 50 ml, 1 vial;
Microtiter plate sealers: 3 sheets;
Plastic Sealable Bag: 1 unit.
Storage
Store the kit reagents at 2-8°C. For more detailed information, please download the following document on our website.

Citations
Have you cited DEIA073 in a publication? Let us know and earn a reward for your research.

Related Products

Human HDV IgG ELISA Kit (DEIA071)
Human HDV IgM ELISA Kit (DEIA072)
HDV IgM ELISA Kit (DEIA1896)
Hepatitis Delta Virus (HDV) Antibody ELISA Kit (DEIA7770)

Customer Reviews

Write a review, share your experiences with others and get rewarded !
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket

References

Are hepatitis delta virus (HDV) genotypes important to determine the disease progression and therapy responses?

JOURNAL OF VIRAL HEPATITIS

Authors: Spaan, M.; Carey, I.; Bruce, M.; Shang, D.; Dusheiko, G.; Agarwal, K.

Viral Hepatitis Etiology, Epidemiology, Transmission, Diagnostics, Treatment, and Prevention

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Authors: Lanini, Simone; Ustianowski, Andrew; Pisapia, Raffaella; Zumla, Alimuddin; Ippolito, Giuseppe

Viral hepatitis is a major global public health problem affecting hundreds of millions of people and is associated with significant morbidity and mortality. Five major biologically unrelated hepatotropic viruses cause most of the global burden of viral hepatitis. Hepatitis B and hepatitis C are associated with a significant number of chronic infections. Most deaths from viral hepatitis are due to hepatitis B and hepatitis C. An estimated 257 million people were living with HBV and 71 million people were living with HCV. Most people are asymptomatic. New diagnostics and highly effective, pangenotypic direct-acting antivirals provide opportunities to cure and eradicate chronic hepatitis C virus infection.

Online Inquiry

Name:
Phone: *
E-mail Address: *
Technology Interest:
Type of Organization:
Service & Products Interested: *
Project Description:

Related Products

Related Resources

Ordering Information

Payment methods we support:
Invoice / Purchase Order
Credit card

Inquiry Basket